The U.S. Centers for Disease Control and Prevention has approved a new ultrasound test that can detect the presence of a woman’s cervix and other signs of pregnancy in women who have a low-risk pregnancy test.
The new test, which has a sensitivity of 93 percent, has been available for more than a year and is the first to test for the cervix, a small opening that can move and change during pregnancy.
The new test is based on a technology developed by a team at the University of Washington, which is using the same technology used to test the uterus for cervical cancer.
The test also can detect a woman with an infection, as well as for a woman who is pregnant or breastfeeding.
The CDC has issued two warnings to doctors, who have not yet received the test.
“The screening tool we’ve developed is not perfect,” said Dr. Paul D. Kuczynski, the agency’s director of the National Center for Injury Prevention and Control.
“The tool has not been validated.
It’s still a very crude tool.”
The new ultrasound tool is about the size of a credit card, and the researchers are hoping it will be used by more women.
But even if it is used in a clinical setting, the new test will not be 100 percent accurate, because it does not include the tissue that normally forms the cervicle.
The researchers said the ultrasound test would be more useful for women who already have an accurate test, and that its sensitivity could be reduced if a woman does not have a normal cervix.
The test is being developed by the Seattle Women’s Health Center and the UW, and it has been tested by more than 700 women in the Seattle area, with 98 percent passing the test, according to a news release.
In the U.K., the new ultrasound technique was tested in an attempt to detect cervical cancer, but it was not approved because it did not include cervical tissue.
The Seattle Women, the nation’s largest health center, is one of the country’s largest providers of cervical cancer screenings.
It was founded by a woman named Margaret and her husband, who found out that their daughter had a rare form of the disease when she was a teenager.
Margaret has since died and her daughter has not developed the cancer.
“They’ve tried everything to get the test approved, and they’ve gotten nothing,” said Margaret Kuczynska, a Seattle native who is now a professor at the UW.
“I feel like it’s an incredible opportunity for us to do something that would be so beneficial for the women who need it.”
The test’s makers are also hoping to sell it to hospitals, which are now testing the test on a wide variety of women in an effort to identify high-risk women and offer preventive care.
“We’re working on a plan to help these hospitals test the test in the future,” said John McAfee, the company’s chief technology officer.
“This is one part of a larger effort that’s already being implemented.”
The Seattle test is part of the ongoing effort by the agency to improve its cervical screening tool.
It is part in a push to have the cervical cancer screening tests become part of every woman’s routine.
The CDC said it has begun testing the new tool in the Portland, Oregon, area and is in talks with health care providers in New York City to test in other major cities.
In April, the CDC announced it would test the new method in all major U.C.L.A. health systems in partnership with a health system in Florida.